Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Avalon Globocare (NQ: AVCO )

0.4777 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 6, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.4777
Bid (Size) 0.4111 (4)
Ask (Size) 0.4800 (19)
Prev. Close 0.4777
Today's Range 0.4777 - 0.4777
52wk Range 0.4006 - 1.190
Shares Outstanding 85,405,919
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Tempest Therapeutics (NASDAQ:TPST) stock moved upwards by 34.4% to $2.81 during Thursday's after-market session. The market value of their outstanding shares is at $29.0 million. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Avalon Globocare (NASDAQ:AVCO) stock rose 14.8% to $0.54 during Tuesday's after-market session. The market value of their outstanding shares is at $47.8 million. 
Via Benzinga

Performance

YTD
-43.32%
-43.32%
1 Month
-11.83%
-11.83%
3 Month
-31.77%
-31.77%
6 Month
-39.96%
-39.96%
1 Year
-51.23%
-51.23%

More News

Read More
NASDAQ Biotech AVCO makes Big Moves Filing 16 New Patent Applications, Co-Inventors are leading International Universities & Cellular Therapy Developers; Avalon Globocare (NASDAQ: AVCO)
Via Get News
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence COVID-19 Intellectual Property
NASDAQ Biotech AVCO makes Big Moves Filing 16 New Patent Applications, Co-Inventors are leading International Universities and Cellular Therapy Developers; Avalon Globocare Corp. (NASDAQ: AVCO)
Via Viz Release
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
NASDAQ Roundtable: $JAZZ signs Licensing agreement with $HOWL Today: Can $AVCO a Leading global developer of cell-based Technologies and Therapeutics be next? Avalon Globocare Corp.  (NASDAQ: AVCO)
Via Viz Release
NASDAQ Roundtable: $JAZZ signs Licensing agreement with $HOWL Today: Can $AVCO a Leading global developer of cell-based Technologies & Therapeuticsbe next? Avalon Globocare Corp. (NASDAQ: AVCO)
Via Get News
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Cell-based Technologies & Therapeutics Global Developer Expands its Immuno-Oncology (mRNA)-based Platform. IND Application on the Horizon for this rising NASDAQ Company: Avalon Globocare Corp (NASDAQ:
Via Get News
Cell-based Technologies and Therapeutics Global Developer Expands its Immuno-Oncology (mRNA)-based Platform. IND Application on the Horizon for this rising NASDAQ Company: Avalon Globocare Corp (NASDAQ: AVCO)
Via Viz Release
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Leading global developer of cell-based technologies and therapeutics Expands its Cellular Immuno-Oncology Platform. NASDAQ Company Avalon Globocare Corp (NASDAQ: AVCO) could be the next big Biotech.
Via Viz Release
Leading global developer of cell-based technologies & therapeutics Expands its Cellular Immuno-Oncology Platform. NASDAQ Company Avalon Globocare Corp (NASDAQ: AVCO)could be the next big Biotech.
Via Get News
Topics Artificial Intelligence
Exposures Artificial Intelligence
Avalon GloboCare Adds CAR-NK Cell Therapies To Expand Cellular Immuno-Oncology Platform
Via Benzinga
Leading global developer of cell-based technologies and therapeutics Expands its Cellular Immuno-Oncology Platform. NASDAQ Company Avalon Globocare Corp (NASDAQ: AVCO) could be the next big Biotech.
Via Viz Release
Avalon Globocare Corps (NASDAQ: AVCO) Filtration Tech Could Help Stop Life-Threatening Cytokine Storm in COVID-19 Patients. AVCO could be the next big Biotech
Via Viz Release
Topics Artificial Intelligence
Exposures Artificial Intelligence COVID-19
NASDAQ Company offers Life Saving Medical Advances; AI & Immunotherapy for Cancer & Immune Related Diseases Including COVID-19: Avalon GloboCare Corp. (NASDAQ: AVCO)
Via Get News
Topics Artificial Intelligence
Exposures Artificial Intelligence COVID-19
NASDAQ Company offers Life Saving Medical Advances; AI and Immunotherapy for Cancer and Immune Related Diseases Including COVID-19: Avalon GloboCare Corp. (NASDAQ: AVCO)
Via Viz Release
Topics Artificial Intelligence
Exposures Artificial Intelligence COVID-19
Year End Update for this Up & Coming NASDAQ at the forefront of innovations in healthcare Featuring AI & Immunotherapies. Avalon GloboCare Corp. (NASDAQ:AVCO); Is AVCO the Next BFRI?
Via Get News
Topics Artificial Intelligence
Exposures Artificial Intelligence
Year End Update for this Up and Coming NASDAQ at the forefront of innovations in healthcare Featuring AI and Immunotherapies. Avalon GloboCare Corp. (NASDAQ:AVCO); Is AVCO the Next BFRI?
Via Viz Release
Topics Artificial Intelligence
Exposures Artificial Intelligence COVID-19
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
NASDAQ at the forefront of innovations in healthcare. Avalon GloboCare Corp. (NASDAQ:AVCO): AVCO’s Filtration Tech Could Help Stop Life-Threatening Cytokine Storm in COVID-19 Patients
Via Get News
Exposures COVID-19
NASDAQ at the forefront of innovations in healthcare. Avalon GloboCare Corp. (NASDAQ:AVCO): AVCO's Filtration Tech Could Help Stop Life-Threatening Cytokine Storm in COVID-19 Patients
Via Viz Release
Exposures COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.